Home
News
Screeners
Insights
Beta Drugs
1,847.
80
+183.10
(+11.00%)
Market Cap
₹2,054.99 Cr
PE Ratio
39.88
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+11.00%
1M
-10.93%
6M
+40.36%
1Y
+1.51%
5Y
+269.60%
View Company Insights
Latest news about Beta Drugs
Beta Drugs gets Azerbaijan approval for oncology products, eyes FY27 sales
Sep 22, 2026
Beta Drugs received regulatory approval from Azerbaijan for its oncology products. The company aims to commence sales from this approval in FY27. The development expands Beta Drugs' international presence in the oncology segment.
Beta Drugs Q1FY27 net profit rises 41% to ₹165 Mn on strong sales
Jul 28, 2026
Beta Drugs completes Nivian Lifesciences acquisition
May 26, 2026
Beta Drugs Achieves Regulatory Milestones in Azerbaijan and Philippines Markets
Apr 22, 2026
Beta Drugs Acquires 66% Stake in IVF Specialist Nivian Lifesciences for ₹69.4 Crore
Jan 12, 2026
More news about Beta Drugs
09
Jan 26
Beta Drugs to Acquire 66.09% Stake in Nivian Life Sciences for ₹694 Million
Beta Drugs announces acquisition of 66.09% controlling stake in Nivian Life Sciences for ₹694 million. This strategic investment provides Beta Drugs with majority control and enhances its presence in the pharmaceutical sector. The substantial acquisition demonstrates the company's commitment to growth through strategic partnerships and investments in life sciences.
21
Nov 25
Beta Drugs Secures Approval for Main Board Listing, Marking Significant Milestone
Beta Drugs, a pharmaceutical company, has received approval to list its equity shares on the main board of the stock exchange, transitioning from the SME Emerge platform. This move is expected to provide the company with access to a broader investor base, enhanced market visibility, and potentially improved trading liquidity. The transition also implies higher compliance and disclosure standards for Beta Drugs.
Beta Drugs
1,847.
80
+
183.
10
(+
11.
00
%)
1 Year Returns:
+1.51%
Industry Peers
Sun Pharmaceutical
1,750.30
(+
0.
30
%)
Divis Laboratories
9,111.00
(-
0.
86
%)
Torrent Pharmaceuticals
4,596.80
(+
0.
94
%)
Zydus Life Science
1,133.50
(+
1.
45
%)
Laurus Labs
2,008.10
(-
0.
22
%)
Cipla
1,320.00
(+
0.
46
%)
Dr Reddys Laboratories
1,228.50
(-
1.
29
%)
Mankind Pharma
2,285.30
(-
0.
01
%)
Aurobindo Pharma
1,599.20
(+
1.
29
%)
Lupin
1,928.60
(-
1.
80
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar